# BioAge Labs, Inc.: filings

BIOA · Nasdaq · CIK 1709941 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bioa.md) · [Financials](/companies/bioa/financials.md) · [Filings](/companies/bioa/filings.md) · [Insiders](/companies/bioa/insiders.md)

## Reports and events: 32 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 47, 8-K 17, 3 12, 144 10, SCHEDULE 13G/A 8, 10-Q 6, CORRESP 6, UPLOAD 5, S-8 3, SC 13G 3, 10-K 2, 424B5 2, 4/A 2, ARS 2, DEF 14A 2, DEFA14A 2, DRS/A 2, DRSLTR 2, S-1/A 2, S-3 2, S-3/A 2, SC 13D 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, CERT 1, D 1, DRS 1, EFFECT 1, S-1 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 20:15 ET | [8-K](/filings/0001193125-26-412300.md) | 8.01 Other events | 0001193125-26-412300 |
| 2026-08-05 | 21:00 ET | [10-Q](/filings/0001193125-26-335407.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335407 |
| 2026-08-05 | 20:55 ET | [8-K](/filings/0001193125-26-335368.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335368 |
| 2026-06-12 | 12:00 ET | [8-K](/filings/0001193125-26-268518.md) | 5.07 Shareholder vote results | 0001193125-26-268518 |
| 2026-05-08 | 13:10 ET | [8-K](/filings/0001193125-26-213472.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213472 |
| 2026-05-08 | 13:05 ET | [10-Q](/filings/0001193125-26-213466.md) | Quarterly report, period 2026-03-31 | 0001193125-26-213466 |
| 2026-04-21 | 20:05 ET | [DEF 14A](/filings/0001193125-26-166738.md) | Proxy statement, period 2026-06-10 | 0001193125-26-166738 |
| 2026-03-24 | 13:15 ET | [10-K](/filings/0001193125-26-120873.md) | Annual report, period 2025-12-31 | 0001193125-26-120873 |
| 2026-03-24 | 13:10 ET | [8-K](/filings/0001193125-26-120864.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-120864 |
| 2026-01-22 | 21:34 ET | [8-K](/filings/0001193125-26-019536.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-019536 |
| 2026-01-20 | 14:05 ET | [8-K](/filings/0001193125-26-016046.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-016046 |
| 2026-01-12 | 14:10 ET | [8-K](/filings/0001193125-26-009911.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009911 |
| 2025-12-04 | 14:05 ET | [8-K](/filings/0001193125-25-307541.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-307541 |
| 2025-11-06 | 21:55 ET | [10-Q](/filings/0001193125-25-270012.md) | Quarterly report, period 2025-09-30 | 0001193125-25-270012 |
| 2025-11-06 | 21:50 ET | [8-K](/filings/0001193125-25-269986.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269986 |
| 2025-08-06 | 20:45 ET | [10-Q](/filings/0000950170-25-104176.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104176 |
| 2025-08-06 | 20:35 ET | [8-K](/filings/0000950170-25-104151.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104151 |
| 2025-06-09 | 20:15 ET | [8-K](/filings/0000950170-25-083746.md) | 5.07 Shareholder vote results | 0000950170-25-083746 |
| 2025-06-04 | 13:00 ET | [8-K](/filings/0000950170-25-081409.md) | 8.01 Other events | 0000950170-25-081409 |
| 2025-05-06 | 20:40 ET | [10-Q](/filings/0000950170-25-064552.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064552 |
| 2025-05-06 | 20:35 ET | [8-K](/filings/0000950170-25-064547.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064547 |
| 2025-04-17 | 20:05 ET | [DEF 14A](/filings/0000950170-25-055371.md) | Proxy statement, period 2025-06-05 | 0000950170-25-055371 |
| 2025-03-20 | 21:04 ET | [10-K](/filings/0000950170-25-042759.md) | Annual report, period 2024-12-31 | 0000950170-25-042759 |
| 2025-03-20 | 20:54 ET | [8-K](/filings/0000950170-25-042747.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-042747 |
| 2024-11-07 | 21:40 ET | [10-Q](/filings/0000950170-24-123445.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123445 |
| 2024-11-07 | 21:35 ET | [8-K](/filings/0000950170-24-123437.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123437 |
| 2024-10-04 | 00:21 ET | [SC 13D](/filings/0001104659-24-106374.md) | Ownership report, active investor | 0001104659-24-106374 |
| 2024-09-30 | 00:34 ET | [SC 13D](/filings/0001104659-24-104494.md) | Ownership report, active investor | 0001104659-24-104494 |
| 2024-09-27 | 20:05 ET | [8-K](/filings/0001193125-24-227949.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-24-227949 |
| 2024-09-25 | 10:06 ET | [S-1/A](/filings/0001193125-24-225155.md) | Registration statement, amended | 0001193125-24-225155 |
| 2024-09-18 | 20:04 ET | [S-1/A](/filings/0001193125-24-221367.md) | Registration statement, amended | 0001193125-24-221367 |
| 2024-09-03 | 20:02 ET | [S-1](/filings/0001193125-24-212046.md) | Registration statement | 0001193125-24-212046 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.